Celgene (Nasdaq: CELG) halts trials Oct 19, 2017 21:55:45 GMT Quote Select PostDeselect PostLink to PostMemberGive GiftBack to Top Post by norfoster on Oct 19, 2017 21:55:45 GMT Celgene stops two trials for Crohn's disease. Shares are down drastically after this news. alphastreet.com/b5c024f0
Celgene (Nasdaq: CELG) halts trials Oct 19, 2017 23:41:23 GMT JHam likes this Quote Select PostDeselect PostLink to PostMemberGive GiftBack to Top Post by RLC on Oct 19, 2017 23:41:23 GMT Oct 19, 2017 21:55:45 GMT norfoster said:Celgene stops two trials for Crohn's disease. Shares are down drastically after this news. alphastreet.com/b5c024f0Damn that really sucks. I know some folks with Crohn's and that's an awful disease. Hate to see things like this...
